Marshall Wace
OPTN

Marshall Wace’s OptiNose OPTN Stock Holding History

Marshall Wace’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-20,508
Closed -$449K – 2843
2024
Q1 		$449K Buy
+20,508
New +$455K ﹤0.01% 1973
2023
Q3 		– Sell
-7,251
Closed -$134K – 2546
2023
Q2 		$134K Buy
7,251
+5,262
+265% +$124K ﹤0.01% 2294
2023
Q1 		$57.6K Hold
1,989
– – ﹤0.01% 2531
2022
Q4 		$55.2K Buy
+1,989
New +$75.5K ﹤0.01% 2836
2021
Q1 		– Sell
-2,255
Closed -$140K – 2757
2020
Q4 		$140K Hold
2,255
– – ﹤0.01% 1778
2020
Q3 		$132K Sell
2,255
-1,156
-34% -$85.6K ﹤0.01% 1504
2020
Q2 		$380K Sell
3,411
-4,151
-55% -$295K ﹤0.01% 1271
2020
Q1 		$509K Buy
7,562
+7,305
+2,842% +$736K 0.01% 970
2019
Q4 		$35K Buy
+257
New +$33.3K ﹤0.01% 1573

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Marshall Wace's OPTN Position: Q2 2024 in Review

Marshall Wace sold out of OptiNose (OPTN) in Q2 2024, closing a stake of 20,508 shares — an estimated $449K sold.

Marshall Wace first reported a position in OPTN in Q4 2019 and held it in 9 quarters. The position peaked at $509K in Q1 2020. 84 funds tracked by Wall St. Rank hold OPTN as of Q2 2024.

  • Marshall Wace reported no remaining OptiNose position as of Q2 2024 after selling out during the quarter.
  • Marshall Wace sold 20,508 OptiNose shares in Q2 2024, an estimated $449K.
  • Marshall Wace first reported a position in OptiNose in Q4 2019 and held it in 9 quarters.
  • Marshall Wace's OptiNose position peaked at $509K in Q1 2020.
  • 84 funds tracked by Wall St. Rank held OptiNose as of Q2 2024.

Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.